Why Is the Unacceptable Acceptable? Pathways for Improved Screening and Early Diagnosis of Alpha1-Antitrypsin Deficiency (AATD)
Improving Screening and Early Diagnosis of Alpha-1 Antitrypsin Deficiency (AATD): Why Is the Unacceptable, Acceptable?Expert Insights
To facilitate the diagnosis and management of alpha-1 antitrypsin deficiency (AATD), clinicians require an understanding of the patient and clinical characteristics that should prompt screening, including a family history and signs of lung or liver involvement. This educational tool supports an easy translation of knowledge and encourages informed decision making for screening and testing patients for AATD. Access expert commentary, resources, and an animated video to be shared with patients who have a high probability of AATD, to increase awareness around common conditions related to AATD, how it is screened, and how to communicate with their healthcare team.
Faculty: Caroline Jouhourian, MD; Cheryl Pirozzi MD, MS
Expiration Date: February 24, 2024